Ta-Chung Chao - Search Results

Year	Number of Results
2003	4
2004	2
2005	3
2006	8
2007	3
2008	2
2009	1
2010	4
2011	6
2012	6
2013	2
2014	5
2015	4
2016	3
2017	3
2018	4
2019	8
2020	3
2021	5
2022	12
2023	3

1

A systemic review of taxanes and their side effects in metastatic breast cancer.

Lai JI, Chao TC, Liu CY, Huang CC, Tseng LM. Lai JI, et al. Among authors: chao tc. Front Oncol. 2022 Oct 11;12:940239. doi: 10.3389/fonc.2022.940239. eCollection 2022. Front Oncol. 2022. PMID: 36303832 Free PMC article.

2

Intravenous Immunoglobulin to Suppress Progression in a Patient With Advanced Breast Cancer.

Lin KL, Chao TC, Chen MH. Lin KL, et al. Among authors: chao tc. J Breast Cancer. 2022 Jun;25(3):253-258. doi: 10.4048/jbc.2022.25.e8. Epub 2022 Feb 17. J Breast Cancer. 2022. PMID: 35380017 Free PMC article.

3

Relationship between environmental carcinogens and EGFR targeting anti-tumor agents in head and neck cancer.

Chao TC. Chao TC. J Chin Med Assoc. 2010 Sep;73(9):457-8. doi: 10.1016/S1726-4901(10)70098-8. J Chin Med Assoc. 2010. PMID: 20875617 Free article. No abstract available.

4

ASO Visual Abstract: Prevalence of Tumor Genomic Alterations in Homologous Recombination Repair Genes Among Taiwanese Breast Cancers.

Huang CC, Tsai YF, Liu CY, Lien PJ, Lin YS, Chao TC, Feng CJ, Chen YJ, Lai JI, Phan NN, Hsu CY, Chiu JH, Tseng LM. Huang CC, et al. Among authors: chao tc. Ann Surg Oncol. 2022 Dec;29(Suppl 3):618-619. doi: 10.1245/s10434-022-12264-y. Ann Surg Oncol. 2022. PMID: 36042100 No abstract available.

5

Prevalence of Tumor Genomic Alterations in Homologous Recombination Repair Genes Among Taiwanese Breast Cancers.

Huang CC, Tsai YF, Liu CY, Lien PJ, Lin YS, Chao TC, Feng CJ, Chen YJ, Lai JI, Phan NN, Hsu CY, Chiu JH, Tseng LM. Huang CC, et al. Among authors: chao tc. Ann Surg Oncol. 2022 Jun;29(6):3578-3590. doi: 10.1245/s10434-022-11347-0. Epub 2022 Feb 28. Ann Surg Oncol. 2022. PMID: 35226219

6

The clinical impacts of molecular subtyping by multigene assay on hormone receptor-positive breast cancers.

Liu YL, Hsu CY, Feng CJ, Lien PJ, Huang CC, Lin YS, Wang YL, Chao TC, Liu CY, Chiu JH, Tsai YF, Tseng LM. Liu YL, et al. Among authors: chao tc. J Chin Med Assoc. 2022 Mar 1;85(3):324-330. doi: 10.1097/JCMA.0000000000000657. J Chin Med Assoc. 2022. PMID: 34907993

7

IKZF3 amplification frequently occurs in HER2-positive breast cancer and is a potential therapeutic target.

Lin CY, Yu CJ, Shen CI, Liu CY, Chao TC, Huang CC, Tseng LM, Lai JI. Lin CY, et al. Among authors: chao tc. Med Oncol. 2022 Sep 30;39(12):242. doi: 10.1007/s12032-022-01812-x. Med Oncol. 2022. PMID: 36180600

8

Correction to: CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin-proteasome pathway in ER + breast cancer.

Lin CY, Yu CJ, Liu CY, Chao TC, Huang CC, Tseng LM, Lai JI. Lin CY, et al. Among authors: chao tc. Clin Transl Oncol. 2022 Nov;24(11):2251-2253. doi: 10.1007/s12094-022-02928-2. Clin Transl Oncol. 2022. PMID: 36087247 No abstract available.

9

The Effectiveness of Hydrodissection with 5% Dextrose for Persistent and Recurrent Carpal Tunnel Syndrome: A Retrospective Study.

Chao TC, Reeves KD, Lam KHS, Li TY, Wu YT. Chao TC, et al. J Clin Med. 2022 Jun 27;11(13):3705. doi: 10.3390/jcm11133705. J Clin Med. 2022. PMID: 35806998 Free PMC article.

10

CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin-proteasome pathway in ER + breast cancer.

Lin CY, Yu CJ, Liu CY, Chao TC, Huang CC, Tseng LM, Lai JI. Lin CY, et al. Among authors: chao tc. Clin Transl Oncol. 2022 Nov;24(11):2120-2135. doi: 10.1007/s12094-022-02881-0. Epub 2022 Aug 2. Clin Transl Oncol. 2022. PMID: 35917055

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results